Reduced Nurr1 expression increases the vulnerability of mesencephalic dopamine neurons to MPTP-induced injury

Journal of Neurochemistry

Volumn 73, Issue 5, 1999, Pages 2218-2221

  Le, Wei Dong ^a   Conneely, Orla M ^a   He, Y ^a   Jankovic, Joseph ^a   Appel, Stanley H ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

1 Methyl 4 phenyl 1,2,3,6 tetrahydropyridine; Dopaminergic neurons; Knockout mice; Mesencephalon; Nurr1; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; BRAIN PROTEIN; NEUROTOXIN; NUCLEAR RECEPTOR RELATED FACTOR 1; UNCLASSIFIED DRUG;

AGE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYO; GENE MUTATION; KNOCKOUT GENE; LOCOMOTION; MESENCEPHALON; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBSTANTIA NIGRA;

ANIMALIA;

EID: 0032692692     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.02218.x     Document Type: Article

References (25)

1. Burns R. S., Chiueh C. C., Markey S. P., Ebert M. H., Jacobowitz D. M., and Kopin I. J. (1983) A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA 80, 4546-4550.
2. Castillo S. O., Baffi J. S., Palkovits M., Goldstein D. S., Kopin I. J., Witta J., Magnuson M. A., and Nikodem V. M. (1998) Dopamine biosynthesis is selectively abolished in substantia nigra/ventral tegmental area but not in hypothalamic neurons in mice with targeted disruption of the Nurr1 gene. Mol. Cell. Neurosci. 11, 36-46.
3. 209A) in 100 patients with younger onset Parkinson's disease. Neurology 50, 513-514.
4. Fearnley J. and Lees A. (1994) Pathology of Parkinson's disease, in Neurodegenerative Diseases (Calne D. B., ed), pp. 545-554. W. B. Saunders Co., Philadelphia.
5. Gasser T., Muller-Myhsok B., Wszolek Z. K., Oehlmann R., Calne D. B., Bonifati V., Bereznai B., Fabrizio E., Vieregge P., and Horstmann R. D. (1998) A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat. Genet. 18, 262-265.
6. Ichinose H., Ohye T., Suzuki T., Sumi-Ichinose C., Nomura T., Hagino Y., and Nagatsu T. (1999) Molecular cloning of the human Nurr1 gene: characterization of the human gene and cDNAs. Gene 230, 233-239.
7. Jenner P. and Olanow W. (1998) Understanding cell death in Parkinson's disease. Ann. Neurol. 44 (Suppl. 1), S72-S84.
8. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., and Shimizu N. (1998) Mutations in the Parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605-608.
9. Kruger R., Vieira-Saecker A. M., Kuhn W., Berg D., Muller T., Kuhnl N., Fuchs G. A., Storch A., Hungs M., Woitalla D., Przuntek H., Epplen J. T., Schols L., and Riess O. (1999) Increased susceptibility to sporadic Parkinson's disease by a certain α-synuclein/ apolipoprotein E genotype. Ann. Neurol. 45, 611-617.
10. Langston J. W. (1998) Epidemiology versus genetics in Parkinson's disease: progress in resolving an age-old debate. Ann. Neurol. 44 (Suppl. 1), S45-S52.
11. Law S. W., Conneely O. M., DeMayo F. J., and Malley B. W. (1992) Identification of a new brain-specific transcription factor, Nurr1. Mol. Endocrinol. 16, 2129-2135.
12. 3H]-GBR12935 to measure dopaminergic nerve terminal growth into the developing rat striatum. Dev. Brain Res. 67, 375-377.
13. Le W. D., Zou L. L., Conneely O. M., He Y., Jankovic J., and Appel S. H. (1998) Selective agenesis of mesencephalic dopaminergic neurons in Nurr1 deficient mice. Mov. Disord. 13 (Suppl. 2), 184.
14. Magest H. V., Rilke O., Bravo R., Senger G., and Kroczek R. A. (1994) NOT, a human immediate-early response gene closely related to the steroid/thyroid hormone receptor NAK1/TR3. Mol. Endocrinol. 8, 1583-1591.
15. Pakkenberg B., Moller A., Gundersen H. J. G., Mouritzen Dam A., and Pakkenberg H. (1991) The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method. J. Neurol. Neurosurg. Psychiatry 54, 30-33.
16. Piccini P., Burn D. J., Ceravolo R., Maraganore D., and Brooks D. J. (1999) The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins. Ann. Neurol. 45, 577-582.
17. Polymeropoulos M. H., Lavedan C., Leroy E., Ide S. E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E. S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W. G., Lazzarini A. M., Duvoisin R. C., Di Iorio G., Golbe L. I., and Nussbaum R. L. (1997) Mutation in the a-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047.
18. Saucedo-Cardenas O. and Conneely O. M. (1996) Comparative distribution of Nurr1 and Nur77 nuclear receptors in the mouse central nervous system. J. Mol. Neurosci. 7, 51-63.
19. Saucedo-Cardenas O., Quintana-Hau J. D., Le W. D., Smidt M. P., Cox J. J., Mayo F. D., Burbach J. P. H., and Conneely O. M. (1998) Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc. Natl Acad. Sci. USA 95, 4013-4018.
20. Sundstrom E., Henrikson B. G., Mohammed A. H., and Souverbie F. (1994) MPTP-treated mice: a useful model for Parkinson's disease?, in Toxin Induced Models of Neurological Disorders (Woodruff M. L. and Nonneman A. J., eds), pp. 121-137. Plenum, New York.
21. Tanner C. M. (1989) The role of environmental toxins in the etiology of Parkinson's disease. Trends Neurosci. 12, 49-54.
22. Tori T., Kawarai T., Nakamura S., and Kawakami H. (1999) Organization of the human orphan nuclear receptor Nurr1 gene. Gene 23, 225-232.
23. Wang W. W., Khajavi M., Patel B. J., Jankovic J., and Ashizawa T. (1998) The G209A mutation in the α-synuclein gene is not detected in familial cases with Parkinson's disease of non-Greek/ Italian populations. Arch. Neurol. 55, 1521-1523.
24. Zetterstrom R. H., Williams R., Perlmann T., and Olson L. (1996) Cellular expression of the immediate early transcription factors Nurr1 and NGFI-B suggests a gene regulatory role in several brain regions including the nigro-striatal dopamine system. Mol. Brain Res. 41, 111-120.
25. Zetterstrom R. H., Solomin L., Jansson L., Hoffer B. J., Olson L., and Perlmann T. (1997) Dopamine neuron agenesis in Nurr1-deficient mice. Science 276, 248-250.